Davis Jennifer L. 4

What Happened

• Jennifer L. Davis, a director of AbbVie Inc., was granted 1,118 restricted stock units (RSUs) on 2026-05-08. The filing reports an acquisition at $0.00 per unit (award), so there was no cash exchanged at grant. This is a compensation award (transaction code A), not a market purchase or sale.

Key Details

• Transaction date: 2026-05-08; Filing date (Form 4): 2026-05-12 (appears timely; within the 2-business-day filing window).
• Number of units awarded: 1,118 RSUs; reported price: $0.00; immediate cash value: $0 (units convert to shares later).
• Shares owned after transaction: not specified in the provided filing details.
• Footnote: RSUs were awarded under the AbbVie Amended and Restated 2013 Incentive Stock Program and will be paid one-for-one in AbbVie common stock on the earlier of the director’s separation from service, death, or a change in control.

Context

• RSUs are deferred equity awards that do not represent current tradable shares until they vest/are settled; they are commonly used for director compensation and do not by themselves indicate a buy/sell sentiment.